1. Home
  2. CRL
  3. CRL News

Latest Charles River Laboratories International Inc. (CRL) News on April 19, 2025

Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025
CRL

Insider Monkey

2 days ago

Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

CRL

MT Newswires

2 days ago

Baird Adjusts Price Target on Charles River Laboratories International to $118 From $101, Keeps Neutral Rating

Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call
CRL

Business Wire

4 days ago

Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call

Strength Seen in Charles River (CRL): Can Its 6.9% Jump Turn into More Strength?
CRL

Zacks

4 days ago

Strength Seen in Charles River (CRL): Can Its 6.9% Jump Turn into More Strength?

CRL

MT Newswires

5 days ago

TD Cowen Adjusts Charles River Laboratories International's PT to $105 From $179, Keeps Hold Rating

CRL

MT Newswires

5 days ago

BofA Securities Cuts Charles River Laboratories International Price Target to $150 From $185

CRL

MT Newswires

8 days ago

Baird Adjusts PT on Charles River Laboratories International to $101 From $155, Keeps Neutral Rating

CRL

MT Newswires

8 days ago

Deutsche Bank Adjusts Price Target on Charles River Laboratories International to $140 From $210

Why Charles River Laboratories International, Inc. (CRL) Went Down On Thursday?
CRL

Insider Monkey

8 days ago

Why Charles River Laboratories International, Inc. (CRL) Went Down On Thursday?

CRL

Morningstar Research

9 days ago

Analyst Report: Charles River Laboratories International, Inc.

CRL

MT Newswires

9 days ago

Barclays Adjusts Price Target on Charles River Laboratories International to $145 From $160

Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?
CRL

Zacks

9 days ago

Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?

Bausch + Lomb (BLCO) Moves 13.9% Higher: Will This Strength Last?
CRL

Zacks

9 days ago

Bausch + Lomb (BLCO) Moves 13.9% Higher: Will This Strength Last?

CRL

MT Newswires

10 days ago

Evercore ISI Adjusts PT on Charles River Laboratories International to $135 From $175, Maintains In Line Rating

CRL

MT Newswires

11 days ago

Goldman Sachs Adjusts Charles River Laboratories International PT to $150 From $170, Maintains Neutral Rating

CRL

Morningstar Research

16 days ago

Analyst Report: Charles River Laboratories International, Inc.

CRL

MT Newswires

19 days ago

Baird Adjusts Charles River Laboratories International Price Target to $155 From $173, Maintains Neutral Rating

Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate
CRL

Zacks

19 days ago

Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate

CRL

MT Newswires

25 days ago

Charles River, Valo Health Identify First Lupus Treatment Candidate Using Logica AI Platform

Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform
CRL

Business Wire

25 days ago

Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform

Why Charles River Laboratories International, Inc. (CRL) is Among the Best Diagnostics Stocks to Invest in Right Now
CRL

Insider Monkey

a month ago

Why Charles River Laboratories International, Inc. (CRL) is Among the Best Diagnostics Stocks to Invest in Right Now

Charles River (CRL) Up 1.9% Since Last Earnings Report: Can It Continue?
CRL

Zacks

a month ago

Charles River (CRL) Up 1.9% Since Last Earnings Report: Can It Continue?

CRL

MT Newswires

a month ago

Goldman Sachs Downgrades Charles River Laboratories International to Neutral From Buy, Adjusts Price Target to $170 From $190

Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers
CRL

StockStory

a month ago

Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

CRL

Argus Research

a month ago

Analyst Report: Charles River Laboratories Int

CRL

Argus Research

a month ago

Market Digest: CRL, DOCU

3 Reasons CRL is Risky and 1 Stock to Buy Instead
CRL

StockStory

a month ago

3 Reasons CRL is Risky and 1 Stock to Buy Instead

Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
CRL

Simply Wall St.

a month ago

Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Charles River Laboratories to Present at Barclays Global Healthcare Conference
CRL

Business Wire

a month ago

Charles River Laboratories to Present at Barclays Global Healthcare Conference

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4
CRL

StockStory

a month ago

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

CRL

MT Newswires

2 months ago

Charles River Laboratories Shares Rise After Citigroup Upgrade

CRL

MT Newswires

2 months ago

Citigroup Upgrades Charles River Laboratories International to Neutral From Sell, Adjusts Price Target to $175 From $155

CRL

MT Newswires

2 months ago

Redburn Atlantic Upgrades Charles River Laboratories International to Neutral From Sell, Adjusts PT to $188 From $171

Bell Global Equities Sold Charles River Laboratories International (CRL) Due To Its Potential For On-going Risk To Earnings
CRL

Insider Monkey

2 months ago

Bell Global Equities Sold Charles River Laboratories International (CRL) Due To Its Potential For On-going Risk To Earnings

Charles River Laboratories International's (NYSE:CRL) Soft Earnings Don't Show The Whole Picture
CRL

Simply Wall St.

2 months ago

Charles River Laboratories International's (NYSE:CRL) Soft Earnings Don't Show The Whole Picture

SGH and Charles River team up for CGMP cell banking services
CRL

Hospital Management

2 months ago

SGH and Charles River team up for CGMP cell banking services

Charles River Announces Agreement with Singapore General Hospital
CRL

Business Wire

2 months ago

Charles River Announces Agreement with Singapore General Hospital

Deciphering Charles River (CRL) International Revenue Trends
CRL

Zacks

2 months ago

Deciphering Charles River (CRL) International Revenue Trends

UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings
CRL

StockStory

2 months ago

UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings

CRL

MT Newswires

2 months ago

TD Cowen Adjusts Price Target on Charles River Laboratories International to $179 From $182, Keeps Hold Rating

CRL

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 02/24/2025

Charles River Laboratories International Full Year 2024 Earnings: EPS Misses Expectations
CRL

Simply Wall St.

2 months ago

Charles River Laboratories International Full Year 2024 Earnings: EPS Misses Expectations

CRL

MT Newswires

2 months ago

Stephens Cuts Charles River Laboratories International Price Target to $190 From $240

CRL

MT Newswires

2 months ago

Deutsche Bank Adjusts Charles River Laboratories International Price Target to $210 From $215, Maintains Buy Rating

CRL

MT Newswires

2 months ago

JPMorgan Adjusts Price Target on Charles River Laboratories International to $165 From $175, Maintains Neutral Rating

CRL

MT Newswires

2 months ago

Baird Adjusts Price Target on Charles River Laboratories International to $173 From $177, Maintains Neutral Rating

CRL

MT Newswires

2 months ago

Barclays Adjusts PT on Charles River Laboratories International to $160 From $166, Maintains Equalweight Rating

Charles River Laboratories International Inc (CRL) Q4 2024 Earnings Call Highlights: Navigating ...
CRL

GuruFocus.com

2 months ago

Charles River Laboratories International Inc (CRL) Q4 2024 Earnings Call Highlights: Navigating ...

CRL

Thomson Reuters StreetEvents

2 months ago

Q4 2024 Charles River Laboratories International Inc Earnings Call

CRL

Morningstar Research

2 months ago

Analyst Report: Charles River Laboratories International, Inc.

Analyst Sees Charles River As Preclinical Leader But Maintains Neutral Stance
CRL

Benzinga

2 months ago

Analyst Sees Charles River As Preclinical Leader But Maintains Neutral Stance

Charles River Laboratories (CRL) Tops Q4 Earnings and Revenue Estimates
CRL

Zacks

2 months ago

Charles River Laboratories (CRL) Tops Q4 Earnings and Revenue Estimates

Charles River Laboratories (NYSE:CRL) Posts Better-Than-Expected Sales In Q4
CRL

StockStory

2 months ago

Charles River Laboratories (NYSE:CRL) Posts Better-Than-Expected Sales In Q4

CRL

MT Newswires

2 months ago

Charles River Laboratories Q4 Higher Earnings Higher, Revenue Lower; 2025 Guidance Issued

CRL

Associated Press Finance

2 months ago

Charles River: Q4 Earnings Snapshot

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL

Business Wire

2 months ago

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance

Earnings To Watch: Charles River Laboratories (CRL) Reports Q4 Results Tomorrow
CRL

StockStory

2 months ago

Earnings To Watch: Charles River Laboratories (CRL) Reports Q4 Results Tomorrow

Gear Up for Charles River (CRL) Q4 Earnings: Wall Street Estimates for Key Metrics
CRL

Zacks

2 months ago

Gear Up for Charles River (CRL) Q4 Earnings: Wall Street Estimates for Key Metrics

Is Now the Right Time to Hold on to Charles River Stock?
CRL

Zacks

2 months ago

Is Now the Right Time to Hold on to Charles River Stock?

CRL

MT Newswires

2 months ago

Conduit Pharmaceuticals, Charles River Laboratories Partner to Evaluate Potential Lupus Treatment

Charles River Laboratories (CRL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
CRL

Zacks

2 months ago

Charles River Laboratories (CRL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Charles River Laboratories International, Inc. (CRL) Expands AI-Powered Digital Pathology Collaboration with Deciphex
CRL

Insider Monkey

2 months ago

Charles River Laboratories International, Inc. (CRL) Expands AI-Powered Digital Pathology Collaboration with Deciphex

Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions
CRL

Business Wire

2 months ago

Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions

Are Investors Undervaluing Charles River Laboratories International, Inc. (NYSE:CRL) By 39%?
CRL

Simply Wall St.

2 months ago

Are Investors Undervaluing Charles River Laboratories International, Inc. (NYSE:CRL) By 39%?

CRL

MT Newswires

2 months ago

Morgan Stanley Adjusts Charles River Laboratories International's Price Target to $184 From $220

CRL Gears Up for Q4 Earnings: Here's What You Need to Know
CRL

Zacks

3 months ago

CRL Gears Up for Q4 Earnings: Here's What You Need to Know

Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call
CRL

Business Wire

3 months ago

Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call

CRL

MT Newswires

3 months ago

Goldman Sachs Adjusts Charles River Laboratories International Price Target to $190 From $220, Maintains Buy Rating

Charles River downgraded to Market Perform from Outperform at William Blair
CRL

TipRanks

3 months ago

Charles River downgraded to Market Perform from Outperform at William Blair

Charles River Launches Apollo for CRADL to Boost Research, Stock Rises
CRL

Zacks

3 months ago

Charles River Launches Apollo for CRADL to Boost Research, Stock Rises

CRL

MT Newswires

3 months ago

William Blair Downgrades Charles River Laboratories International to Market Perform From Outperform

CRL

MT Newswires

3 months ago

TD Cowen Adjusts Charles River Laboratories International Price Target to $182 From $227

RiverWater Partners Sustainable Value Strategy Trimmed its Investment in Charles River Laboratories (CRL)
CRL

Insider Monkey

3 months ago

RiverWater Partners Sustainable Value Strategy Trimmed its Investment in Charles River Laboratories (CRL)

What Makes Charles River Labs (CRL) an Investment Bet?
CRL

Insider Monkey

3 months ago

What Makes Charles River Labs (CRL) an Investment Bet?

Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences
CRL

Business Wire

3 months ago

Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences

CRL

MT Newswires

3 months ago

Charles River Laboratories Mid-term Sales Growth Structurally Slowed Down, UBS Says

CRL

MT Newswires

3 months ago

UBS Downgrades Charles River Laboratories International to Neutral From Buy, Adjusts Price Target to $185 From $250

Charles River and Akron link to integrate cytokines into cell therapy
CRL

Pharmaceutical Technology

3 months ago

Charles River and Akron link to integrate cytokines into cell therapy

Will CRL Stock Gain From Integration of Akron Bio's CSS Product Line?
CRL

Zacks

3 months ago

Will CRL Stock Gain From Integration of Akron Bio's CSS Product Line?

CRL

MT Newswires

3 months ago

Charles River Laboratories Partners With Akron Bio to Improve Cancer Treatment Platforms

Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform
CRL

Business Wire

3 months ago

Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform

CRL

Morningstar Research

3 months ago

Analyst Report: Charles River Laboratories International, Inc.

Charles River CEO reveals drop in 2025 revenue outlook at JP Morgan
CRL

Pharmaceutical Technology

3 months ago

Charles River CEO reveals drop in 2025 revenue outlook at JP Morgan

CRL

MT Newswires

3 months ago

Jefferies Adjusts Price Target on Charles River Laboratories International to $169 From $196, Keeps Hold Rating

CRL

MT Newswires

3 months ago

Baird Adjusts Price Target on Charles River Laboratories International to $177 From $197, Keeps Neutral Rating

Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
CRL

Business Wire

3 months ago

Charles River Laboratories to Present at J.P. Morgan Healthcare Conference

Should You Retain Charles River Stock in Your Portfolio Now?
CRL

Zacks

4 months ago

Should You Retain Charles River Stock in Your Portfolio Now?

Earnings are growing at Charles River Laboratories International (NYSE:CRL) but shareholders still don't like its prospects
CRL

Simply Wall St.

4 months ago

Earnings are growing at Charles River Laboratories International (NYSE:CRL) but shareholders still don't like its prospects

CRL

MT Newswires

4 months ago

Deutsche Bank Adjusts Charles River Laboratories International Price Target to $245 From $250

CRL

MT Newswires

4 months ago

Morgan Stanley Trims Price Target on Charles River Laboratories International to $220 From $225, Keeps Equalweight Rating

Why Is Charles River (CRL) Down 8.9% Since Last Earnings Report?
CRL

Zacks

4 months ago

Why Is Charles River (CRL) Down 8.9% Since Last Earnings Report?

CRL Stock to Gain From the Global Biotech Incubator Program Launch
CRL

Zacks

4 months ago

CRL Stock to Gain From the Global Biotech Incubator Program Launch

Charles River Introduces Global Biotech Incubator Program
CRL

Business Wire

4 months ago

Charles River Introduces Global Biotech Incubator Program

Charles River Laboratories to Present at Evercore ISI Investor Conference
CRL

Business Wire

5 months ago

Charles River Laboratories to Present at Evercore ISI Investor Conference

At US$200, Is It Time To Put Charles River Laboratories International, Inc. (NYSE:CRL) On Your Watch List?
CRL

Simply Wall St.

5 months ago

At US$200, Is It Time To Put Charles River Laboratories International, Inc. (NYSE:CRL) On Your Watch List?

Is it the Right Time to Hold Charles River Stock in Your Portfolio?
CRL

Zacks

5 months ago

Is it the Right Time to Hold Charles River Stock in Your Portfolio?

CRL

MT Newswires

5 months ago

Goldman Sachs Adjusts Price Target on Charles River Laboratories International to $220 From $240, Maintains Buy Rating

CRL

MT Newswires

5 months ago

Redburn Atlantic Adjusts PT on Charles River Laboratories International to $171 From $151, Maintains Sell Rating

CRL

MT Newswires

5 months ago

Baird Adjusts Price Target on Charles River Laboratories International to $197 From $211, Maintains Neutral Rating

CRL

Argus Research

5 months ago

Market Digest: APA, CBRL, CRL, DUK, SWKS, WWW, HUBS

Share on Social Networks: